Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

80.36
Delayed Data
As of 4:00pm ET
 -0.03 / -0.04%
Today’s Change
64.18
Today|||52-Week Range
83.79
+9.26%
Year-to-Date
US exporters line up behind tax code overhaul
6:12am / FT.com - Paid Partner Content
What's Driving Lilly's (LLY) Shares after 2016 Decline?
Feb 16 / Zacks.com - Paid Partner Content
Better Buy: Eli Lilly and Company vs. Johnson & Johnson
Feb 18 / MotleyFool.com - Paid Partner Content
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb 16 / Zacks.com - Paid Partner Content
Merrimack (MACK): What Awaits the Stock in Q4 Earnings?
Feb 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Eli Lilly, T-Mobile, Oracle an...
Feb 16 / Zacks.com - Paid Partner Content
Clovis, Tesaro Soar on Astrazeneca Phase Three News
Feb 17 / TheStreet.com - Paid Partner Content
DexCom Is a Great Healthcare Stock to Buy Now
Feb 15 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb 17 / Zacks.com - Paid Partner Content
Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next?
Feb 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close80.39
Today’s open80.17
Day’s range80.11 - 80.87
Volume3,178,822
Average volume (3 months)5,511,359
Market cap$88.7B
Dividend yield2.59%
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+14.16%
Earnings growth (this year)+15.34%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+6.33%
P/E ratio34.9
Price/Sales3.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.19+0.35%
AGNAllergan-0.19-0.08%
CELGCelgene-1.72-1.42%
ABTAbbott Laboratories+0.32+0.72%
Data as of 4:01pm ET, 02/21/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$0.95
Annual revenue (last year)$21.2B
Annual profit (last year)$2.7B
Net profit margin12.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts


Search for Jobs